G Lagier
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 15
- Pharmacovigilance and Adverse Drug Reactions 13
-
- Drug-Induced Hepatotoxicity and Protection 5
- Pharmaceutical industry and healthcare 2
- Co-authors
- J Jouglard (3 shared papers)Bernard Bégaud (3 shared papers)J C Evreux (2 shared papers)A Castot (11 shared papers)Xavier Thirion (3 shared papers)Christine Le Beller (1 shared paper)Marie‐Christine Jaulent (1 shared paper)Cédric Bousquet (1 shared paper)
- Journals
- Drug Information Journal (2 papers)Biochemical Pharmacology (1 paper)Drug Safety (1 paper)European Addiction Research (1 paper)Drug and Alcohol Dependence (1 paper)
- Partner nations
- FranceNew Zealand
In The Last Decade
G Lagier
57 papers receiving 1.0k citations
G Lagier's Hit Papers
Peers
Comparison fields: 5 of 102
- Toxicology 314
- Geriatrics and Gerontology 54
- Pharmacology 114
- Pharmacology 205
- Dermatology 52
Countries citing papers authored by G Lagier
This map shows the geographic impact of G Lagier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Lagier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Lagier more than expected).
Fields of papers citing papers by G Lagier
This network shows the impact of papers produced by G Lagier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Lagier. The network helps show where G Lagier may publish in the future.
Co-authors
The 25 scholars most cited alongside G Lagier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France]. Hit paper breakdown → | 1985 | 581 |
| 2 | 2005 | 77 | |
| 3 | [French pharmacovigilance database system: examples of utilisation]. | 1996 | 52 |
| 4 | 2001 | 50 | |
| 5 | 2005 | 32 | |
| 6 | [Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997]. | 1999 | 24 |
| 7 | [Observation of illicit or misused psychotropic drugs (O.P.P.I.D.U.M.): five years of surveillance of products consumed by drug addicts at Marseille]. | 1997 | 20 |
| 8 | 2002 | 20 | |
| 9 | [Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid]. | 1983 | 19 |
| 10 | [Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings]. | 1987 | 19 |
| 11 | [Bismuth encephalopathies outside France (author's transl)]. | 1980 | 13 |
| 12 | [Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings]. | 1987 | 11 |
| 13 | [Drug-induced hemolytic anemia. Results of consensus conferences]. | 1988 | 10 |
| 14 | [Interstitial pneumopathies: criteria of drug side-effects. Results of consensus meetings]. | 1989 | 10 |
| 15 | [Drug-induced renal insufficiency. Results of consensus meetings]. | 1989 | 9 |
| 16 | [A minor case of ergotism appearing to be connected with a potentialisation of ergotamine tartrate by erythromycine ethyl-succinate (author's transl)]. | 1980 | 9 |
| 17 | 2003 | 8 | |
| 18 | 1989 | 7 | |
| 19 | [Hypoglycemia in 2 patients treated with perhexiline maleate]. | 1977 | 7 |
| 20 | [Strong withdrawal syndrome with benzodiazpines (six cases) (author's transl)]. | 1980 | 6 |
About G Lagier
G Lagier is a scholar working on Toxicology, Pharmacology, Pediatrics, Perinatology and Child Health, Molecular Biology and General Health Professions, having authored 60 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (13 papers), Pharmaceutical studies and practices (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Pharmaceutical Economics and Policy (3 papers), Alcoholism and Thiamine Deficiency (3 papers), Health, Medicine and Society (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Pharmaceutical industry and healthcare (2 papers). The work is most often cited by research in Toxicology (314 citations), Geriatrics and Gerontology (54 citations), Pharmacology (114 citations), Pharmacology (205 citations) and Dermatology (52 citations). G Lagier has collaborated with scholars based in France and New Zealand. Frequent co-authors include J Jouglard, Bernard Bégaud, J C Evreux, A Castot, Xavier Thirion, Christine Le Beller, Marie‐Christine Jaulent, Cédric Bousquet, Alain Venot and Jean‐Louis Imbs. Their work appears in journals such as Drug Information Journal, Biochemical Pharmacology, Drug Safety, European Addiction Research and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.